Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indutrade is a Sweden-based publicly traded industrial and technology group that acquires, owns, and develops decentralized operating companies with specialized technical products and solutions. The group spans multiple business areas, including Industrial & Engineering, Infrastructure & Construction, Process, Energy & Water, Life Science, and Technology & Systems Solutions. Its Life Science business area serves pharmaceutical, healthcare, diagnostics, and food-sector customers with components, medical technology products, production equipment, and system solutions, but Indutrade itself is not a drug-development biotech or pharma company. The company operates through more than 220 subsidiaries across more than 30 countries and emphasizes long-term ownership, entrepreneurship, and decentralized management. For a biotech analyst, Indutrade is better understood as a strategic industrial owner with exposure to healthcare and life science supply chains rather than as a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indutrade.